|
ACET
|
Adicet Bio, Inc.
|
US
|
NASDAQ
|
|
ACHL
|
Achilles Therapeutics plc
|
US
|
NASDAQ
|
|
ADAG
|
Adagene Inc.
|
US
|
NASDAQ
|
|
ADAP
|
Adaptimmune Therapeutics plc
|
US
|
NASDAQ
|
|
ALXO
|
ALX Oncology Holdings Inc.
|
US
|
NASDAQ
|
|
AMAM
|
Ambrx Biopharma Inc.
|
US
|
NYSE
|
|
APGN
|
Apexigen, Inc.
|
US
|
NASDAQ
|
|
ARGX
|
argenx SE
|
US
|
NASDAQ
|
|
AVTX
|
Avalo Therapeutics, Inc.
|
US
|
NASDAQ
|
|
BCAB
|
BioAtla, Inc.
|
US
|
NASDAQ
|
|
BCEL
|
Atreca, Inc.
|
US
|
NASDAQ
|
|
BOLT
|
Bolt Biotherapeutics, Inc.
|
US
|
NASDAQ
|
|
CADL
|
Candel Therapeutics, Inc.
|
US
|
NASDAQ
|
|
CGEM
|
Cullinan Management, Inc.
|
US
|
NASDAQ
|
|
CKPT
|
Checkpoint Therapeutics, Inc.
|
US
|
NASDAQ
|
|
CNCR
|
Loncar Cancer Immunotherapy ETF
|
US
|
NASDAQ
|
|
CRBU
|
Caribou Biosciences, Inc.
|
US
|
NASDAQ
|
|
CRVS
|
Corvus Pharmaceuticals, Inc.
|
US
|
NASDAQ
|
|
EVAX
|
Evaxion Biotech A/S
|
US
|
NASDAQ
|
|
FSTX
|
F-star Therapeutics, Inc.
|
US
|
NASDAQ
|